Krzysztof Bujko

Maria Sklodowska-Curie National Research Institute of Oncology

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Piotr Potemski

Medical University of Lodz

POLAND

View details

Jolanta Szelachowska

Head of Clinic Gynaecological Oncology

Uniwersytet Medyczny im Piastów Śląskich we Wrocławiu

POLAND

View details

Marek Szczepkowski

Józef Piłsudski University of Physical Education in Warsaw

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Krzysztof Bujko

Research Interests

Explore related searches

Contact this professor

Articles (10)

Are we already in the era of total neoadjuvant treatment for rectal cancer?

Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study

Noncancer Deaths in the PETACC 6 Trial

Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies

Carcinoma of the anal canal and anal margin

Clinical practice guidelines for diagnosis and treatment of colon (C18) and rectosigmoid junction (C19) cancer

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data

Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study

Rectal cancer (C20)

Collaborators (3)

Piotr Potemski

Jolanta Szelachowska

Marek Szczepkowski

Make your next move.

Krzysztof Bujko

Research Interests

Explore related searches

Contact this professor

Articles (10)

Are we already in the era of total neoadjuvant treatment for rectal cancer?

Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch &amp; Wait Database: a retrospective, international, multicentre registry study

Noncancer Deaths in the PETACC 6 Trial

Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies

Carcinoma of the anal canal and anal margin

Clinical practice guidelines for diagnosis and treatment of colon (C18) and rectosigmoid junction (C19) cancer

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data

Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study

Rectal cancer (C20)

Collaborators (3)

Piotr Potemski

Jolanta Szelachowska

Marek Szczepkowski

Make your next move.

Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study